CompletedPhase 1NCT02971202

Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)

Studying MODY

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vanderbilt University
Principal Investigator
Justin M Gregory, MD
Vanderbilt University School of Medicine
Intervention
Hyperinsulinemic, euglycemic clamp(drug)
Enrollment
33 enrolled
Eligibility
13-51 years · All sexes
Timeline
20162019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02971202 on ClinicalTrials.gov

Other trials for MODY

Additional recruiting or active studies for the same condition.

See all trials for MODY

← Back to all trials